Ezetimibe In Addition To Atorvastatin Therapy On The Plaque Composition In Patients With Acute Myocardial Infarction.
Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to examine the effect of the cholesterol lowering agent Ezetimibe
when used in addition to optimal treatment with Atorvastatin in patients with acute
ST-Elevation Myocardial Infarction (STEMI) who have not been in prior statin therapy.
An area with arteriosclerosis not demanding intervention in a coronary vessel other than the
infarct related is used as measuring point and is examined at time of the infarction and
after 12 month using intravascular ultrasound and optical coherence tomography. At the same
time the same techniques are used to examine the implanted stent.